Who
Christopher Nixon Cox
Director
Company insider
Files Form 4 as: Director, Newsmax; Director, Alto Neuroscience.
In numbers
- Trades disclosed
- 15
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 1 Feb 2024
- Last trade
- 20 May 2026
- Last filed
- 21 May 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 May 2026filed 21 May 2026 | NMAX Newsmaxoption or derivative · Broadcasting & cable | SEC FORM 4 Code A | —23,940 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | NMAX Newsmaxoption or derivative · Broadcasting & cable | SEC FORM 4 Code A | —23,940 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | ANRO Alto Neuroscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,958 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | ANRO Alto Neuroscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,958 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | ANRO Alto Neuroscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | $85K7,189 at $11.82 | filing |
| 2 Jan 2026filed 6 Jan 2026 | ANRO Alto Neuroscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | $85K7,189 at $11.82 | filing |
| 13 May 2025filed 15 May 2025 | ANRO Alto Neuroscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,287 at $0.00 | filing |
| 28 Mar 2025filed 4 Apr 2025 | NMAX Newsmaxoption or derivative · Broadcasting & cable | SEC FORM 4 Code A | —17,500 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | ANRO Alto Neuroscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | $80K25,236 at $3.17 | filing |
| 6 Feb 2024filed 7 Feb 2024 | ANRO Alto Neuroscienceoption or derivative · Biotechnology | SEC FORM 4 Code C | —1,250,000 at $0.00 | filing |
| 6 Feb 2024filed 7 Feb 2024 | ANRO Alto Neuroscienceoption or derivative · Biotechnology | SEC FORM 4 Code C | —281,917 at $0.00 | filing |
| 6 Feb 2024filed 7 Feb 2024 | ANRO Alto NeuroscienceBiotechnology | SEC FORM 4 Code C | —588,898 | filing |
| 6 Feb 2024filed 7 Feb 2024 | ANRO Alto NeuroscienceBiotechnology | SEC FORM 4 Code C | —126,755 | filing |
| 1 Feb 2024filed 5 Feb 2024 | ANRO Alto Neuroscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,574 at $0.00 | filing |
| 1 Feb 2024filed 5 Feb 2024 | ANRO Alto Neuroscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | $55K4,623 at $11.88 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.